Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
46.84
+2.09 (4.67%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Supernus Pharmaceuticals Employees
Supernus Pharmaceuticals had 778 employees as of December 31, 2025. The number of employees increased by 104 or 15.43% compared to the previous year.
Employees
778
Change (1Y)
104
Growth (1Y)
15.43%
Revenue / Employee
$998,500
Profits / Employee
-$37,296
Market Cap
2.72B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Trulieve Cannabis | 5,000 |
| HUTCHMED (China) | 1,796 |
| ANI Pharmaceuticals | 970 |
| Prestige Consumer Healthcare | 890 |
| Indivior Pharmaceuticals | 838 |
| BioCryst Pharmaceuticals | 435 |
| Harrow | 373 |
SUPN News
- 24 days ago - Supernus Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Supernus Pharmaceuticals to Participate in June Investor Conferences - GlobeNewsWire
- 6 weeks ago - Supernus Pharmaceuticals Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference - GlobeNewsWire
- 7 weeks ago - Supernus Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 7 weeks ago - Supernus Pharmaceuticals Earnings release: Q1 2026 - Filings
- 7 weeks ago - Supernus Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Supernus Announces First Quarter 2026 Financial Results - GlobeNewsWire